StockData
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. (SBFM) stock

SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.54−0.06 (-2.31%)

Close on Nov 17, 2026Market cap $9.85MP/E –Yield –

Sunshine Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Sunshine Biopharma's price to book ratio was 0.2× on Nov 11, 2026, against 54.6× a year earlier. Over the last 5 years it ranged from 0.0× to 100.4×, with a median of 1.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−46.1
2025Dec 31, 202546.3×−1.6
2024Dec 31, 202447.9×+47.3
2023Dec 29, 20230.6×+0.0
2022Dec 30, 20220.6×+0.6
2014Jan 31, 20140.0×+0.0
2013Dec 31, 20130.0×+0.0
2012Dec 31, 20120.0×+0.0
2011Dec 30, 20110.0×–

More Sunshine Biopharma figures

See a number that looks wrong?